NCT03479723View on ClinicalTrials.gov

Identification of Predictors for Coronary Plaque Erosion in Patients With Acute Coronary Syndrome

CompletedOBSERVATIONAL
Enrollment

1,793

Participants

Timeline

Start Date

December 1, 2017

Primary Completion Date

December 1, 2019

Study Completion Date

August 1, 2024

Conditions
Acute Coronary Syndrome
Trial Locations (1)

02114

Massachusetts General Hospital, Boston

All Listed Sponsors
lead

Massachusetts General Hospital

OTHER

NCT03479723 - Identification of Predictors for Coronary Plaque Erosion in Patients With Acute Coronary Syndrome | Biotech Hunter | Biotech Hunter